In Cirrhosis, Less Activity Equals Worse Outcomes The lower the daily step count, the higher the risk of hospitalization and death Mar 23, 2022
Rinvoq Approved for UC; HCC Combo Flops; Disney Grants Pass to IBS Patient News and commentary from the world of gastroenterology and hepatology Mar 17, 2022
Default Order in Hospitals' EHR Doubles Hepatitis C Screening About 70% of patients completed screening with intervention versus 38% with conventional alert Mar 17, 2022
Can a Wearable for Sleep Positioning Help With Nocturnal Reflux? In sham-controlled trial, active device reduced GERD symptoms Mar 16, 2022
Getting a Cure to Hepatitis C Patients Who Use Injection Drugs Randomized trial found that HCV care housed at a harm reduction center improved chances Mar 14, 2022
Fecal Microbiome Markers Detect Pancreatic Cancer With 'High Accuracy' These markers need to be tested in a prospective cohort before clinical impact can be determined Mar 10, 2022
Robotic Hepatectomy Shows Benefits Over Laparoscopic Surgery Shorter hospital stay, similar perioperative outcomes in matched analysis Mar 10, 2022
Is ctDNA Useful for Surveillance in Resected CRC? Small study suggests no advantage compared to imaging alone or with CEA measurement Mar 08, 2022
EHR 'Nudge' Linked to Fewer C. Diff Tests for Organ Transplant Recipients The program also led to fewer days of antibiotics and cost savings Mar 07, 2022
Traditional Dietary Advice May Be Best for IBS Shows similar efficacy to gluten-free and low FODMAP diets in randomized trial Mar 03, 2022
Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
Surveillance Colonoscopy in IBD Tied to Lower Advanced Cancer Risk Findings bolster guidelines for IBD patients with extensive colitis or left-sided colitis Mar 01, 2022
Ulcerative Colitis With an Unexpected Cause Can the immune response to COVID-19 trigger inflammatory bowel disease? Mar 01, 2022
AGA: Consider De-Prescribing PPIs in Patients With 'Murky' Indications New clinical practice update suggests either abrupt discontinuation or tapering when appropriate Feb 22, 2022
SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Diet News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
Ablating High-Grade Anal Lesions Thwarts Progression to Cancer Screening followed by aggressive therapy shows benefit in phase III ANCHOR study Feb 17, 2022
Universal HCV Screening in Pregnancy Boosts Detection More cases found verses risk-based approach, also IDs perinatal transmission, researcher says Feb 16, 2022
Sotorasib Impresses in Advanced Pancreatic Cancer ORR of 21% in heavily pretreated patients with a KRAS G12C mutation Feb 16, 2022
Novel Strategy Slashes HBV Vertical Transmission Sans Immunoglobulin Cambodian study finds antenatal antiviral effective if used for long enough Feb 15, 2022
High-Deductible Insurance Linked to More Complex Hernias Study suggests delays in care, particularly for those with no health savings account Feb 14, 2022
Pembrolizumab Shows Promise in Advanced Anal Cancer PD-1 inhibitor may be an option for those who have no options Feb 11, 2022
History of Pancreatitis Linked to Severe COVID-19 Outcomes Electronic medical record data reveal greater risk for hospitalization, death after infection Feb 10, 2022
Recurrent Autoimmune Hepatitis Post-Liver Transplant: What Are the Risks? Probability of recurrent disease more than doubled from 5 to 20 years later Feb 09, 2022
Guselkumab Cuts Disease Activity in Crohn's Nearly two-thirds of patients respond to selective p19 IL-23 inhibitor Feb 08, 2022
Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
Simpler Tool Validated for Endoscopic Assessment in Crohn's SEMA-CD should be used as endpoint for clinical trials, researcher argues Jan 26, 2022
Vedolizumab for Ulcerative Colitis Works Best When Given Early Benefit confirmed in real-world data Jan 25, 2022
GICS Roundup: PD-1 Inhibitor Yields 100% Response Rate in dMMR Rectal Cancer Plus: Promising activity in BRAF-mutant CRC, L-asparaginase drug falls short in pancreatic cancer Jan 24, 2022
Adagrasib Promising in KRAS-Mutant GI Cancers The KRAS G12C inhibitor showed a disease control rate of 100% in small study Jan 24, 2022
Combo Treatment Disappoints in Acute Severe Ulcerative Colitis No outcomes boost with addition of 5-ASA agent to corticosteroids in hospitalized patients Jan 23, 2022
Survival Bump in Biliary Cancer With Immunotherapy Plus Chemotherapy Adding durvalumab boosts OS by 1.3 months, first survival improvement in a decade Jan 23, 2022
Immunotherapy Not Additive to Standard of Care for Untreated Metastatic CRC No difference in survival outcomes with add-on nivolumab to chemo, bevacizumab Jan 23, 2022
Patients With IBD Cite Symptom Relief With Online Intervention Tool But experts warns that patients were on the very strict Specific Carbohydrate Diet Jan 22, 2022
Potential New First-Line Options for Unresectable Hepatocellular Carcinoma Tremelimumab-durvalumab improves OS, single-agent durvalumab non-inferior to sorafenib Jan 22, 2022
Which IBD Patients Experience More Severe COVID? Research suggests immunomodulators, incomplete vaccination, and non-mRNA vaccines may play a role Jan 21, 2022
Pre-Op Immunotherapy Combo Makes Headway in Select Gastric Cancers Plus, novel bispecific antibody tested as first-line therapy for advanced gastric/GEJ cancer Jan 21, 2022
Wildlife Photography Doc: Our Empathy Makes Us Human Daniel D'Auria, MD, channeled his burnout into an award-winning pastime Jan 21, 2022
Microbiome Therapy Cut Post-Antibiotic C. Diff Recurrence Phase III trial showed "two-pronged" approach worked, regardless of age, antibiotic type Jan 19, 2022
Doc Who Branded His Initials in Patients' Livers Banned From Practice U.K. transplant surgeon, Simon Bramhall, had pled guilty to two counts of assault back in 2017 Jan 14, 2022
Fatty Liver Disease a Long-COVID Symptom After Severe Cases? In Italian study, over half had metabolic dysfunction-associated fatty liver disease Jan 11, 2022
